JUNGDAWN Co., Ltd. (KOSDAQ:208140)

Silk Road Medical Revenue

JUNGDAWN had revenue of 37.88B KRW in the quarter ending March 31, 2025, a decrease of -11.96%. This brings the company's revenue in the last twelve months to 176.81B, down -6.42% year-over-year. In the year 2024, JUNGDAWN had annual revenue of 181.96B, down -1.91%.

• Revenue (ttm): 176.81B
• Revenue Growth: -6.42%
• P/S Ratio: 0.50
• Revenue / Employee: 642.94M
• Employees: 275
• Market Cap: 88.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	181.96B	-3.54B	-1.91%
Dec 31, 2023	185.49B	2.84B	1.56%
Dec 31, 2022	182.65B	29.03B	18.90%
Dec 31, 2021	153.62B	29.59B	23.86%
Dec 31, 2020	124.03B	-1.79B	-1.42%